Pulmonary Hypertension Group III Workstream

Back to Task Forces & IDDI Workstreams
Group 3 PH science image

This Workstream was founded in March 2021 and is a collaborative platform between industry, academic, regulatory, and patient representatives. Its aim is to strengthen our community’s understanding of PH due to lung diseases. Every month they hold scientific discussions, often from their focus lectures and journal club. 

The Workstream aims to improve the care and daily living of PH group III patients by: 

  • evaluating evidence and epidemiology 
  • defining different phenotypes and endophenotypes 
  • delineating innovative clinical trial endpoints 
  • identifying novel diagnostic, digital solutions, and treatment approaches 


Consensus statements published in Pulmonary Circulation 


Articles published by the Workstream

Working groups have been established to publish four more articles this year, including ‘The Significance of PH in COPD.’ 


PVRI 2024 Congress presentations


Steven Nathan , Inova
Sylvia Nikkho , Bayer